Skip to main content

Claritev Corp

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

CTEV$24.00+5.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. Other Information

On September 15, 2026, Jerome Hogge, Chief Operating Officer, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of up to 17,507 shares of the Company's Class A common stock, covering (i)8,136 shares acquired upon the vesting of restricted stock units and (ii)9,371 shares of previously acquired Company's Class A common stock. This 10b5-1 sales plan will become effective on December 15, 2026 and will terminate on December 15, 2027, subject to earlier termination in accordance with its terms.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.